Rezum System
Boston Scientific · Decision date Sep 3, 2026
What did the FDA decide?
FDA's 510(k) database records K262460 for the Rezum System, submitted by Boston Scientific of Marlborough, Massachusetts. The record lists the device classification as Unit, Electrosurgical, Endoscopic (With Or Without Accessories), regulation number 876.4300, product code KNS, and review under the Gastroenterology/Urology panel. The application was received on 07/17/2026 and decided on 09/03/2026 as Substantially Equivalent (SESE), a 510(k) clearance rather than a PMA approval. The record describes the filing as Traditional, not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan.
The public record does not identify which components or modifications were assessed, nor does it state indications, performance data or review rationale. Those details would sit in the underlying 510(k) documents, which are not included here. The page shows two different last-updated dates, 09/14/2026 and 09/21/2026, across captures of the same record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262460
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Boston Scientific
- Product code
- KNS
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Unit, Electrosurgical, Endoscopic (With Or Without Accessories).
- Applicant
- Boston Scientific
- Product code
- KNS
- FDA device class
- 2
FDA decision timeline
K262460 received
Application receipt date recorded by FDA.
K262460 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- Marlborough, MA
Sources and methodology
- Original FDA record: K262460
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records